Oxidative stress and exhaled breath analysis: A promising tool for detection of lung Cancer

Cancers

Volumn 2, Issue 1, 2010, Pages 32-42

  Chan, Hiang Ping ^a,b   Lewis, Craig ^a,b   Thomas, Paul S ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Exhaled breath analysis; Lung cancer; Oxidative stress

Indexed keywords

CYTOKINE; GOLD NANOPARTICLE; NITRIC OXIDE; PROTEIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; TUMOR MARKER; VOLATILE ORGANIC COMPOUND;

ANALYTIC METHOD; ANALYZER; BIOSENSOR; BIOTECHNOLOGY; BREATH ANALYSIS; CHEMOLUMINESCENCE; COLORIMETRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DNA DAMAGE; EARLY DIAGNOSIS; EXHALED BREATH CONDENSATE; EXPIRED AIR; GAS ANALYSIS; GENE MUTATION; HUMAN; ION MOBILITY SPECTROMETRY; LIPID PEROXIDATION; LIQUID PHASE ANALYSIS; LUNG CANCER; LUNG NON SMALL CELL CANCER; OXIDATIVE STRESS; REPRODUCIBILITY; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT PARAMETERS; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 78751578549     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers2010032     Document Type: Review

References (54)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M.J. Cancer statistics, 2009. CA Cancer J. Clin. 2009, 59, 225-249.
2. Humphrey, L.L.; Teutsch, S.; Johnson, M. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2004, 140, 740-753.
3. Belinsky, S.A. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat. Rev. Cancer. 2004, 4, 707-717.
4. Dominioni, L.; Imperatori, A.; Rovera, F.; Ochetti, A.; Torrigiotti, G.; Paolucci, M. Stage I nonsmall cell lung carcinoma: analysis of survival and implications for screening. Cancer 2000, 89, 2334-2344.
5. Flehinger, B.J.; Kimmel, M.; Melamed, M.R. The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest 1992, 101, 1013-1018.
6. Hecht, S.S. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 2002, 3, 461-469.
7. Kinnula, V.L.; Crapo, J.D. Superoxide dismutases in the lung and human lung diseases. Am. J. Respir. Crit. Care Med. 2003, 167, 1600-1619.
8. Knaapen, A.M.; Gungor, N.; Schins, R.P.; Borm, P.J.; Van Schooten, F.J. Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis 2006, 21, 225-236.
9. Rahman, I.; Biswas, S.K.; Kode, A. Oxidant and antioxidant balance in the airways and airway diseases. Eur. J. Pharmacol. 2006, 533, 222-239.
10. Kharitonov, S.A.; Yates, D.; Robbins, R.A.; Logan-Sinclair, R.; Shinebourne, E.A.; Barnes, P.J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994, 343, 133-135.
11. Liu, J.; Sandrini, A.; Thurston, M.C.; Yates, D.H.; Thomas, P.S. Nitric oxide and exhaled breath nitrite/nitrates in chronic obstructive pulmonary disease patients. Respiration 2007, 74, 617-623.
12. Miekisch, W.; Schubert, J.K.; Noeldge-Schomburg, G.F. Diagnostic potential of breath analysis- focus on volatile organic compounds. Clin. Chim. Acta 2004, 347, 25-39.
13. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am. J. Respir. Crit. Care Med. 2005, 171, 912-930.
14. Corradi, M.; Pesci, A.; Casana, R.; Alinovi, R.; Goldoni, M.; Vettori, M.V.; Cuomo, A. Nitrate in exhaled breath condensate of patients with different airway diseases. Nitric Oxide 2003, 8, 26-30.
15. Liu, C.Y.; Wang, C.H.; Chen, T.C.; Lin, H.C.; Yu, C.T.; Kuo, H.P. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br. J. Cancer 1998, 78, 534-541.
16. Kneepkens, C.M.; Lepage, G.; Roy, C.C. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic. Biol. Med. 1994, 17, 127-160.
17. Paredi, P.; Kharitonov, S.A.; Barnes, P.J. Analysis of expired air for oxidation products. Am. J. Respir. Crit. Care Med. 2002, 166, S31-S37.
18. Van Gossum, A.; Decuyper, J. Breath alkanes as an index of lipid peroxidation. Eur. Respir. J. 1989, 2, 787-791.
19. Gordon, S.M.; Szidon, J.P.; Krotoszynski, B.K.; Gibbons, R.D.; O'Neill, H.J. Volatile organic compounds in exhaled air from patients with lung cancer. Clin. Chem. 1985, 31, 1278-1282.
20. Phillips, M.; Gleeson, K.; Hughes, J.M.; Greenberg, J.; Cataneo, R.N.; Baker, L.; McVay, W.P. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 1999, 353, 1930-1933.
21. Phillips, M.; Cataneo, R.N.; Cummin, A.R.; Gagliardi, A.J.; Gleeson, K.; Greenberg, J.; Maxfield, R.A.; Rom, W.N. Detection of lung cancer with volatile markers in the breath. Chest 2003, 123, 2115-2123.
22. Poli, D.; Carbognani, P.; Corradi, M.; Goldoni, M.; Acampa, O.; Balbi, B.; Bianchi, L.; Rusca, M.; Mutti, A. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir. Res. 2005, 6, 71.
23. Ligor, M.; Ligor, T.; Bajtarevic, A.; Ager, C.; Pienz, M.; Klieber, M.; Denz, H.; Fiegl, M.; Hilbe, W.; Weiss, W.; Lukas, P.; Jamnig, H.; Hackl, M.; Buszewski, B.; Miekisch, W.; Schubert, J.; Amann, A. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clin. Chem. Lab. Med. 2009, 47, 550-560.
24. Song, G.; Qin, T.; Liu, H.; Xu, G.B.; Pan, Y.Y.; Xiong, F.X.; Gu, K.S.; Sun, G.P.; Chen, Z.D. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer 2009, 67, 227-231.
25. Mazzone, P.J.; Hammel, J.; Dweik, R.; Na, J.; Czich, C.; Laskowski, D.; Mekhail, T. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax 2007, 62, 565-568.
26. Westhoff, M.; Litterst, P.; Freitag, L.; Urfer, W.; Bader, S.; Baumbach, J.I. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 2009, 64, 744-748.
27. Barash, O.; Peled, N.; Hirsch, F.R.; Haick, H. Sniffing the unique odor print of non-small-cell lung cancer with gold nanoparticles. Small 2009, 5, 2618-2624.
28. Peng, G.; Tisch, U.; Adams, O.; Hakim, M.; Shehada, N.; Broza, Y.Y.; Billan, S.; Abdah- Bortnyak, R.; Kuten, A.; Haick, H. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat. Nanotechnol. 2009, 4, 669-673.
29. Machado, R.F.; Laskowski, D.; Deffenderfer, O.; Burch, T.; Zheng, S.; Mazzone, P.J.; Mekhail, T.; Jennings, C.; Stoller, J.K.; Pyle, J.; Duncan, J.; Dweik, R.A.; Erzurum, S.C. Detection of lung cancer by sensor array analyses of exhaled breath. Am. J. Respir. Crit. Care Med. 2005, 171, 1286-1291.
30. Di Natale, C.; Macagnano, A.; Martinelli, E.; Paolesse, R.; D'Arcangelo, G.; Roscioni, C.; Finazzi-Agro, A.; D'Amico, A. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens. Bioelectron. 2003, 18, 1209-1218.
31. Dragonieri, S.; Annema, J.T.; Schot, R.; van der Schee, M.P.; Spanevello, A.; Carratu, P.; Resta, O.; Rabe, K.F.; Sterk, P.J. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 2009, 64, 166-170.
32. D'Amico, A.; Pennazza, G.; Santonico, M.; Martinelli, E.; Roscioni, C.; Galluccio, G.; Paolesse, R.; Di Natale, C. An investigation on electronic nose diagnosis of lung cancer. Lung Cancer 2009, doi:10.1016/j.lungcan.2009.11.003, in press.
33. Tran, V.; Chan, H.P.; Thurston, M.C.; Jackson, P.; Lewis, C.; Yates, D.; Bell, G.; Thomas, P.S. Breath analysis of lung cancer patients using an electronic nose detection system. IEEE Sensors J. 2009, in press.
34. Effros, R.M.; Dunning, M.B., 3rd; Biller, J.; Shaker, R. The promise and perils of exhaled breath condensates. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 287, L1073-L1080.
35. Chan, H.P.; Lewis, C.; Thomas, P.S. Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer 2009, 63, 164-168.
36. Liu, J.; Thomas, P.S. Exhaled breath condensate as a method of sampling airway nitric oxide and other markers of inflammation. Med. Sci. Monit. 2005, 11, MT53-62.
37. Liu, J.; Thomas, P.S. Relationship between exhaled breath condensate volume and measurements of lung volumes. Respiration 2007, 74, 142-145.
38. Hunt, J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J. Allergy Clin. Immunol. 2002, 110, 28-34.
39. Liu, J.; Conrad, D.H.; Chow, S.; Tran, V.H.; Yates, D.H.; Thomas, P.S. Collection devices influence the constituents of exhaled breath condensate. Eur. Respir. J. 2007, 30, 807-808.
40. Holz, O. Catching breath: monitoring airway inflammation using exhaled breath condensate. Eur. Respir. J. 2005, 26, 371-372.
41. Chow, S.; Yates, D.H.; Thomas, P.S. Reproducibility of exhaled breath condensate markers. Eur. Respir. J. 2008, 32, 1124-1126.
42. Horvath, I.; Hunt, J.; Barnes, P.J.; Alving, K.; Antczak, A.; Baraldi, E.; Becher, G.; van Beurden, W.J.; Corradi, M.; Dekhuijzen, R.; Dweik, R.A.; Dwyer, T.; Effros, R.; Erzurum, S.; Gaston, B.; Gessner, C.; Greening, A.; Ho, L.P.; Hohlfeld, J.; Jobsis, Q.; Laskowski, D.; Loukides, S.; Marlin, D.; Montuschi, P.; Olin, A.C.; Redington, A.E.; Reinhold, P.; van Rensen, E.L.; Rubinstein, I.; Silkoff, P.; Toren, K.; Vass, G.; Vogelberg, C.; Wirtz, H. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur. Respir. J. 2005, 26, 523-548.
43. Chan, H.P.; Tran, V.; Lewis, C.; Thomas, P.S. Elevated levels of oxidative stress markers in exhaled breath condensate. J. Thorac. Oncol. 2009, 4, 172-178.
44. Khyshiktuev, B.S.; Khyshiktueva, N.A.; Ivanov, V.N. Methods of measuring lipid peroxidation products in exhaled air condensate and their clinical significance. Klin. Lab. Diagn. 1996, 3, 13-15.
45. Dalaveris, E.; Kerenidi, T.; Katsabeki-Katsafli, A.; Kiropoulos, T.; Tanou, K.; Gourgoulianis, K.I.; Kostikas, K. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Lung Cancer 2009, 64, 219-225.
46. Gessner, C.; Kuhn, H.; Toepfer, K.; Hammerschmidt, S.; Schauer, J.; Wirtz, H. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients. Lung Cancer 2004, 43, 215-222.
47. Gessner, C.; Rechner, B.; Hammerschmidt, S.; Kuhn, H.; Hoheisel, G.; Sack, U.; Ruschpler, P.; Wirtz, H. Angiogenic markers in breath condensate identify non-small cell lung cancer. Lung Cancer 2009, doi:10.1016/j.lungcan.2009.06.010, in press.
48. Carpagnano, G.E.; Foschino-Barbaro, M.P.; Mule, G.; Resta, O.; Tommasi, S.; Mangia, A.; Carpagnano, F.; Stea, G.; Susca, A.; Di Gioia, G.; De Lena, M.; Paradiso, A. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer. Am. J. Respir. Crit. Care Med. 2005, 172, 738-744.
49. Carpagnano, G.E.; Spanevello, A.; Carpagnano, F.; Palladino, G.P.; Prato, R.; Martinelli, D.; Digioia, G.; Foschino-Barbaro, M.P. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients. Lung Cancer 2009, 64, 334-340.
50. Han, W.; Wang, T.; Reilly, A.A.; Keller, S.M.; Spivack, S.D. Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients. Respir. Res. 2009, 10, 86.
51. Carpagnano, G.E.; Foschino-Barbaro, M.P.; Resta, O.; Gramiccioni, E.; Carpagnano, F. Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer. Oncology 2004, 66, 180-184.
52. Carpagnano, G.E.; Resta, O.; Foschino-Barbaro, M.P.; Gramiccioni, E.; Carpagnano, F. Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer. Int. J. Biol. Markers 2002, 17, 141-145.
53. Carpagnano, G.E.; Spanevello, A.; Curci, C.; Salerno, F.; Palladino, G.P.; Resta, O.; Di Gioia, G.; Carpagnano, F.; Foschino Barbaro, M.P. IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients. Oncol. Res. 2007, 16, 375-381.
54. Carpagnano, G.E.; Spanevello, A.; Palladino, G.P.; Gramiccioni, C.; Ruggieri, C.; Carpagnano, F.; Foschino Barbaro, M.P. Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link? Lung Cancer 2010, 67, 108-113.